Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.

Dajcs JJ, Thibodeaux BA, Marquart ME, Girgis DO, Traidej M, O'Callaghan RJ.

Antimicrob Agents Chemother. 2004 Jun;48(6):1948-52.

2.

Molecular detection of antimicrobial resistance.

Fluit AC, Visser MR, Schmitz FJ.

Clin Microbiol Rev. 2001 Oct;14(4):836-71, table of contents. Review.

3.

Quinolone resistance mutations in the GrlB protein of Staphylococcus aureus.

Tanaka M, Onodera Y, Uchida Y, Sato K.

Antimicrob Agents Chemother. 1998 Nov;42(11):3044-6.

5.

Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus.

Tanaka M, Onodera Y, Uchida Y, Sato K, Hayakawa I.

Antimicrob Agents Chemother. 1997 Nov;41(11):2362-6.

6.

Cloning and sequencing of a novel gene (recG) that affects the quinolone susceptibility of Staphylococcus aureus.

Niga T, Yoshida H, Hattori H, Nakamura S, Ito H.

Antimicrob Agents Chemother. 1997 Aug;41(8):1770-4.

7.

Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus.

Takenouchi T, Tabata F, Iwata Y, Hanzawa H, Sugawara M, Ohya S.

Antimicrob Agents Chemother. 1996 Aug;40(8):1835-42.

8.

Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus.

Yamagishi J, Kojima T, Oyamada Y, Fujimoto K, Hattori H, Nakamura S, Inoue M.

Antimicrob Agents Chemother. 1996 May;40(5):1157-63.

9.

Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem.

Cambau E, Perani E, Dib C, Petinon C, Trias J, Jarlier V.

Antimicrob Agents Chemother. 1995 Oct;39(10):2248-52.

10.

Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing.

Tokue Y, Sugano K, Saito D, Noda T, Ohkura H, Shimosato Y, Sekiya T.

Antimicrob Agents Chemother. 1994 Mar;38(3):428-31.

11.

gyrA mutations in quinolone-resistant isolates of the fish pathogen Aeromonas salmonicida.

Oppegaard H, Sørum H.

Antimicrob Agents Chemother. 1994 Oct;38(10):2460-4.

12.

Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.

Ito H, Yoshida H, Bogaki-Shonai M, Niga T, Hattori H, Nakamura S.

Antimicrob Agents Chemother. 1994 Sep;38(9):2014-23.

13.

Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.

Kureishi A, Diver JM, Beckthold B, Schollaardt T, Bryan LE.

Antimicrob Agents Chemother. 1994 Sep;38(9):1944-52.

14.

Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones.

Takenouchi T, Ishii C, Sugawara M, Tokue Y, Ohya S.

Antimicrob Agents Chemother. 1995 Jul;39(7):1414-8.

Supplemental Content

Support Center